Tandem Diabetes Care Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	1,015	940.2	747.72	801.22	702.8
Revenue Growth (YoY)	7.93%	25.74%	-6.68%	14.00%	40.89%
Cost of Revenue	468.72	450.63	380.03	388.23	326.58
Gross Profit	546.01	489.57	367.69	412.99	376.22
Selling, General & Admin	434.13	389.82	338.4	335.68	261.51
Research & Development	190	198.88	169.67	139.11	92.05
Operating Expenses	624.14	588.7	508.07	474.8	353.56
Operating Income	-78.12	-99.13	-140.38	-61.81	22.65
Interest Expense	-7.91	-7.42	-9.88	-6.21	-6.04
Interest & Investment Income	13.9	22.1	22.86	6.06	0.67
Earnings From Equity Investments	-14.19	-2.05	-	-	-
Currency Exchange Gain (Loss)	-5.4	-2	-	-	-
Other Non Operating Income (Expenses)	0.59	-0.11	-	0.15	-1.39
EBT Excluding Unusual Items	-91.14	-88.6	-127.41	-61.81	15.9
Merger & Restructuring Charges	-7.27	-	-	-	-
Gain (Loss) on Sale of Investments	-	-2	-	-	-
Asset Writedown	-6.7	-	-14.1	-	-
Legal Settlements	-19.95	-	-	-	-
Other Unusual Items	-	-1.27	-	-	-
Pretax Income	-200.27	-91.87	-220.25	-92.85	15.9
Income Tax Expense	4.44	4.16	2.36	1.74	0.34
Net Income	-204.71	-96.03	-222.61	-94.59	15.57
Net Income to Common	-204.71	-96.03	-222.61	-94.59	15.57
Shares Outstanding (Basic)	67	65	65	64	63
Shares Outstanding (Diluted)	67	65	65	64	64
Shares Change (YoY)	2.80%	0.74%	1.28%	-0.32%	5.51%
EPS (Basic)	-3.04	-1.47	-3.43	-1.47	0.25
EPS (Diluted)	-3.04	-1.47	-3.43	-1.47	0.24
Free Cash Flow	-29.67	4.99	-58.61	16.37	97.18
Free Cash Flow Per Share	-0.44	0.08	-0.90	0.26	1.51
Gross Margin	53.81%	52.07%	49.18%	51.54%	53.53%
Operating Margin	-7.70%	-10.54%	-18.77%	-7.71%	3.22%
Profit Margin	-20.17%	-10.21%	-29.77%	-11.81%	2.21%
Free Cash Flow Margin	-2.92%	0.53%	-7.84%	2.04%	13.83%
EBITDA	-60.46	-82.52	-124.67	-47.48	36.5
EBITDA Margin	-5.96%	-8.78%	-16.67%	-5.93%	5.19%
D&A For EBITDA	17.67	16.61	15.72	14.33	13.85
EBIT	-78.12	-99.13	-140.38	-61.81	22.65
EBIT Margin	-7.70%	-10.54%	-18.77%	-7.71%	3.22%
Effective Tax Rate	-	-	-	-	2.11%

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q